FDA Questions Spray Sunscreen Safety, Efficacy And Monograph Status
This article was originally published in The Pink Sheet Daily
Executive Summary
While the jury is still out on sprays, FDA also uses its June 17 advanced notice of proposed rulemaking to pursue eliminating several other sunscreen delivery formats from the monograph: sunscreen wipes, towelettes, powders, body washes and shampoos.
You may also be interested in...
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.